Table 3.
Resistance rates of Campylobacter isolates represented by travel region defined according to United Nations geoscheme. Intermediate susceptible results are grouped together with resistant results
| Region | N | Ciprofloxacin | Erythromycin | Tetracycline |
|---|---|---|---|---|
| Eastern Africa | 30 | 13 (43.3%) | 0 | 17 (56.7%) |
| Middle Africa | 25 | 13 (52.0%) | 1 (4.0%) | 12 (48.0%) |
| Northern Africa | 36 | 24 (66.7%) | 1 (2.8%) | 18 (50.0%) |
| Southern Africa | 1 | 0 | 0 | 0 |
| Western Africa | 28 | 11 (39.3%) | 1 (3.6%) | 9 (32.1%) |
| Africa total | 120 | 61 (50.8%) | 3 (2.5%) | 56 (46.7%) |
| Caribbean | 3 | 1 | 1 | 0 |
| Central America | 1 | 1 | 0 | 1 |
| South America | 15 | 12 (80%) | 0 | 9 (60.0%) |
| Northern America | 1 | 1 | 0 | 1 |
| America total | 20 | 15 (75.0%) | 1 (5.0%) | 11 (55.0%) |
| Eastern Asia | 1 | 0 | 0 | 0 |
| Southern Asia | 46 | 35 (76.1%) | 7 (15.2%) | 19 (41.3%) |
| Southeastern Asia | 25 | 17 (68.0%) | 1 (4.0%) | 14 (56.0%) |
| Western Asia | 8 | 8 | 0 | 4 |
| Asia total | 80 | 60 (75.0%) | 8 (10.0%) | 37 (46.3%) |
| Eastern Europe | 8 | 4 | 0 | 6 |
| Southern Europe | 17 | 8 (47.1%) | 0 | 6 (35.3%) |
| Western Europe | 16 | 11 (68.8%) | 1 (6.3%) | 10 (62.5%) |
| Europe total | 41 | 23 (56.1%) | 1 (2.4%) | 22 (53.7%) |
| Total | 261 | 159 (60.9%) | 12 (4.6%) | 126 (48.3%) |
If the total number of isolates for a particular region is <10, the percentage of resistance is not mentioned.